-
1
-
-
0036293243
-
Global control of hepatitis B virus infection
-
Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2:395-403.
-
(2002)
Lancet Infect Dis
, vol.2
, pp. 395-403
-
-
Kao, J.H.1
Chen, D.S.2
-
2
-
-
0032801432
-
Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy
-
Bonanni P, Colombai R, Gasparini R, et al. Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy. Pediatr Infect Dis J 1999; 18:677-682.
-
(1999)
Pediatr Infect Dis J
, vol.18
, pp. 677-682
-
-
Bonanni, P.1
Colombai, R.2
Gasparini, R.3
-
3
-
-
0034048304
-
Elimination of new chronic hepatitis B virus infections: Results of the Alaska immunization program
-
Harpaz R, McMahon BJ, Margolis HS, et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis 2000; 181:413-418.
-
(2000)
J Infect Dis
, vol.181
, pp. 413-418
-
-
Harpaz, R.1
McMahon, B.J.2
Margolis, H.S.3
-
4
-
-
0035898929
-
The first five years of universal hepatitis B vaccination in South Africa: Evidence for elimination of HBsAg carriage in under 5-year-olds
-
Tsebe KV, Burnett RT, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine 2001; 19:3919-3926.
-
(2001)
Vaccine
, vol.19
, pp. 3919-3926
-
-
Tsebe, K.V.1
Burnett, R.T.2
Hlungwani, N.P.3
Sibara, M.M.4
Venter, P.A.5
Mphahlele, M.J.6
-
5
-
-
3142532627
-
Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries
-
Basuni AA, Butterworth L, Cooksley G, Locarnini S, Carman WF. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine 2004; 22:2791-2799.
-
(2004)
Vaccine
, vol.22
, pp. 2791-2799
-
-
Basuni, A.A.1
Butterworth, L.2
Cooksley, G.3
Locarnini, S.4
Carman, W.F.5
-
6
-
-
0019985965
-
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast
-
Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 1982; 298:347-350.
-
(1982)
Nature
, vol.298
, pp. 347-350
-
-
Valenzuela, P.1
Medina, A.2
Rutter, W.J.3
Ammerer, G.4
Hall, B.D.5
-
7
-
-
0021337752
-
Antigenic structure of hepatitis B surface antigen: Identification of the 'd' subtype determinant by chemical modification and use of monoclonal antibodies
-
Peterson DL, Paul DA, Lam J, Tribby I, Achord DT Antigenic structure of hepatitis B surface antigen: identification of the 'd' subtype determinant by chemical modification and use of monoclonal antibodies. J Immunol 1984; 132:920-927.
-
(1984)
J Immunol
, vol.132
, pp. 920-927
-
-
Peterson, D.L.1
Paul, D.A.2
Lam, J.3
Tribby, I.4
Achord, D.T.5
-
8
-
-
0022744580
-
Production and immunological analysis of recombinant hepatitis B vaccine
-
Emini EA, Ellis RW, Miller WJ, McAleer WJ, Scolnick EM, Gerety RJ. Production and immunological analysis of recombinant hepatitis B vaccine. J Infect 1986; 13 Suppl A:3-9.
-
(1986)
J Infect
, vol.13
, Issue.SUPPL. A
, pp. 3-9
-
-
Emini, E.A.1
Ellis, R.W.2
Miller, W.J.3
McAleer, W.J.4
Scolnick, E.M.5
Gerety, R.J.6
-
9
-
-
0023470784
-
HBsAG positive reactivity in man not due to hepatitis B virus
-
Coursaget P, Yvonnet B, Bourdil C, et al. HBsAG positive reactivity in man not due to hepatitis B virus. Lancet 1987; 2:1354-1358.
-
(1987)
Lancet
, vol.2
, pp. 1354-1358
-
-
Coursaget, P.1
Yvonnet, B.2
Bourdil, C.3
-
10
-
-
0028057186
-
A novel hepatitis B virus variant in the sera of immunized children
-
Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, Howard CR. A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 1994; 75:443-448.
-
(1994)
J Gen Virol
, vol.75
, pp. 443-448
-
-
Karthigesu, V.D.1
Allison, L.M.2
Fortuin, M.3
Mendy, M.4
Whittle, H.C.5
Howard, C.R.6
-
11
-
-
0030625754
-
The clinical significance of surface antigen variants of hepatitis B virus
-
Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepatitis 1997; 4:11-20.
-
(1997)
J Viral Hepatitis
, vol.4
, pp. 11-20
-
-
Carman, W.F.1
-
12
-
-
0002047543
-
Surface variation of HBV: Scientific and medical relevance
-
Wallace WA, Carman WF. Surface variation of HBV: scientific and medical relevance. Viral Hepatitis Rev 1997; 3:5-16.
-
(1997)
Viral Hepatitis Rev
, vol.3
, pp. 5-16
-
-
Wallace, W.A.1
Carman, W.F.2
-
13
-
-
0029159858
-
Molecular epidemiology of hepatitis B virus vaccine variants in Singapore
-
Oon CJ, Lim GK, Ye Z, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995; 13:699-702.
-
(1995)
Vaccine
, vol.13
, pp. 699-702
-
-
Oon, C.J.1
Lim, G.K.2
Ye, Z.3
-
14
-
-
0032713817
-
Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan
-
Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30:1312-1317.
-
(1999)
Hepatology
, vol.30
, pp. 1312-1317
-
-
Hsu, H.Y.1
Chang, M.H.2
Liaw, S.H.3
Ni, Y.H.4
Chen, H.L.5
-
15
-
-
0035003596
-
Variants within the 'a' determinant of HBs gene in children and adolescents with and without hepatitis B vaccination as part of Thailand's Expanded Program on Immunization (EPI)
-
Theamboonlers A, Chongsrisawat V, Jantaradsamee P, Poovorawan Y. Variants within the 'a' determinant of HBs gene in children and adolescents with and without hepatitis B vaccination as part of Thailand's Expanded Program on Immunization (EPI). Tohoku J Exp Med 2001; 193:197-205.
-
(2001)
Tohoku J Exp Med
, vol.193
, pp. 197-205
-
-
Theamboonlers, A.1
Chongsrisawat, V.2
Jantaradsamee, P.3
Poovorawan, Y.4
-
16
-
-
0035700331
-
Prevalence of vaccine-induced escape mutants of hepatitis B virus in the adult population in China: A prospective study in 176 restaurant employees
-
He C, Nomura F, Itoga S, Isobe K, Nakai T. Prevalence of vaccine-induced escape mutants of hepatitis B virus in the adult population in China: a prospective study in 176 restaurant employees. J. Gastroenterol Hepatol 2001; 16:1373-1377.
-
(2001)
J. Gastroenterol Hepatol
, vol.16
, pp. 1373-1377
-
-
He, C.1
Nomura, F.2
Itoga, S.3
Isobe, K.4
Nakai, T.5
-
17
-
-
0036038911
-
Restoration of replication phenotype of lamivudine resistant hepatitis B virus mutants by compensatory changes in the 'fingers' sub-domain of the viral polymerase selected as a consequence of mutations in the overlapping S gene
-
Torresi J, Earnest-Silveira L, Civitico G, et al. Restoration of replication phenotype of lamivudine resistant hepatitis B virus mutants by compensatory changes in the 'fingers' sub-domain of the viral polymerase selected as a consequence of mutations in the overlapping S gene. Virology 2002; 299:88-99.
-
(2002)
Virology
, vol.299
, pp. 88-99
-
-
Torresi, J.1
Earnest-Silveira, L.2
Civitico, G.3
-
18
-
-
0036059889
-
Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy
-
Torresi J, Earnest-Silveira L, Deliyannis G, et al. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 2002; 293:305-313.
-
(2002)
Virology
, vol.293
, pp. 305-313
-
-
Torresi, J.1
Earnest-Silveira, L.2
Deliyannis, G.3
-
19
-
-
0034040297
-
Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy
-
Yeh CT, Chien RN, Chu CM, Liaw YF. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology 2000; 31:1318-1326.
-
(2000)
Hepatology
, vol.31
, pp. 1318-1326
-
-
Yeh, C.T.1
Chien, R.N.2
Chu, C.M.3
Liaw, Y.F.4
-
20
-
-
0033754947
-
Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy
-
Lok AS-F, Hussain M, Cursano C, et al. Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy. Hepatology 2000; 32:1145-1153.
-
(2000)
Hepatology
, vol.32
, pp. 1145-1153
-
-
Lok, A.S.-F.1
Hussain, M.2
Cursano, C.3
-
21
-
-
0034048756
-
Predictions of the emergence of vaccine-resistant hepatitis B in the Gambia using a mathematical model
-
Wilson JN, Nokes DJ, Carman WF. Predictions of the emergence of vaccine-resistant hepatitis B in the Gambia using a mathematical model. Epidemiol Infect 2000; 124:295-307.
-
(2000)
Epidemiol Infect
, vol.124
, pp. 295-307
-
-
Wilson, J.N.1
Nokes, D.J.2
Carman, W.F.3
-
22
-
-
0142092372
-
The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro
-
Delaney WEt, Yang H, Westland CE, et al. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J Virol 2003; 77:11833-11841.
-
(2003)
J Virol
, vol.77
, pp. 11833-11841
-
-
Delaney, W.E.1
Yang, H.2
Westland, C.E.3
-
23
-
-
0036161381
-
Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation
-
Bock TC, Tillmann HL, Torresi J, et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology 2002; 122:264-273.
-
(2002)
Gastroenterology
, vol.122
, pp. 264-273
-
-
Bock, T.C.1
Tillmann, H.L.2
Torresi, J.3
-
24
-
-
33751514752
-
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
-
Lin SM, Yu ML, Lee CM, et al. Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma. J Hepatol 2007; 46:45-52.
-
(2007)
J Hepatol
, vol.46
, pp. 45-52
-
-
Lin, S.M.1
Yu, M.L.2
Lee, C.M.3
-
25
-
-
13444309139
-
A randomized, controlled trial of combination therapy for chronic hepatitis B: Comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone
-
Chan HL, Leung NW, Hui AY, et al. A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone. Ann Intern Med 2005; 142:240-250.
-
(2005)
Ann Intern Med
, vol.142
, pp. 240-250
-
-
Chan, H.L.1
Leung, N.W.2
Hui, A.Y.3
-
26
-
-
32944458551
-
Chronic hepatitis B: HBeAg seroconversion after pegylated interferon and nucleos(t)ide analogs
-
author reply 1459-1460
-
Janssen HL, Lau GK. Chronic hepatitis B: HBeAg seroconversion after pegylated interferon and nucleos(t)ide analogs. Hepatology 2005; 42:1459; author reply 1459-1460.
-
(2005)
Hepatology
, vol.42
, pp. 1459
-
-
Janssen, H.L.1
Lau, G.K.2
-
27
-
-
34247194561
-
Management of hepatitis B: Summary of a clinical research workshop
-
Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok ASF. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007; 45:1056-1075.
-
(2007)
Hepatology
, vol.45
, pp. 1056-1075
-
-
Hoofnagle, J.H.1
Doo, E.2
Liang, T.J.3
Fleischer, R.4
Lok, A.S.F.5
-
29
-
-
33644818518
-
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
-
Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006; 354:1001-1010.
-
(2006)
N Engl J Med
, vol.354
, pp. 1001-1010
-
-
Chang, T.T.1
Gish, R.G.2
de Man, R.3
-
30
-
-
33644822860
-
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
-
Lai CL, Shouval D, Lok AS, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2006; 354:1011-1020.
-
(2006)
N Engl J Med
, vol.354
, pp. 1011-1020
-
-
Lai, C.L.1
Shouval, D.2
Lok, A.S.3
-
31
-
-
19944428132
-
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial
-
Janssen HL, van Zonneveld M, Senturk H, et al. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 2005; 365:123-129.
-
(2005)
Lancet
, vol.365
, pp. 123-129
-
-
Janssen, H.L.1
van Zonneveld, M.2
Senturk, H.3
-
32
-
-
21244447705
-
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
-
Lau GK, Piratvisuth T, Luo KX, et al. Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 2005; 352:2682-2695.
-
(2005)
N Engl J Med
, vol.352
, pp. 2682-2695
-
-
Lau, G.K.1
Piratvisuth, T.2
Luo, K.X.3
-
33
-
-
4544239807
-
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
-
Marcellin P, Lau GK, Bonino F, et al. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2004; 351:1206-1217.
-
(2004)
N Engl J Med
, vol.351
, pp. 1206-1217
-
-
Marcellin, P.1
Lau, G.K.2
Bonino, F.3
-
34
-
-
33748929265
-
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B
-
Wursthorn K, Lutgehetmann M, Dandri M, et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 2006; 44:675-684.
-
(2006)
Hepatology
, vol.44
, pp. 675-684
-
-
Wursthorn, K.1
Lutgehetmann, M.2
Dandri, M.3
-
35
-
-
42149135950
-
Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication
-
Lutgehetmann M, Volzt T, Quaas A et al. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication. Antivir Ther 2008; 13:57-66.
-
(2008)
Antivir Ther
, vol.13
, pp. 57-66
-
-
Lutgehetmann, M.1
Volzt, T.2
Quaas, A.3
-
36
-
-
34047130122
-
Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B
-
Lampertico P, Marzano A, Levrero M, et al. Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B. Hepatology 2006; 44 Suppl 1:693A.
-
(2006)
Hepatology
, vol.44
, Issue.SUPPL. 1
-
-
Lampertico, P.1
Marzano, A.2
Levrero, M.3
-
37
-
-
35648982926
-
Low resistance to adefovir combined with lamivudine: A 3-year study of 145 lamivudine-resistant hepatitis B patients
-
Lampertico P, Viganò M, Manenti E, Iavarone M, Sablon E, Colombo M. Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients. Gastroenterology 2007; 133:1445-1451.
-
(2007)
Gastroenterology
, vol.133
, pp. 1445-1451
-
-
Lampertico, P.1
Viganò, M.2
Manenti, E.3
Iavarone, M.4
Sablon, E.5
Colombo, M.6
-
38
-
-
34247475757
-
Combination of adefovir dipivoxil with lamivudine vs. adefovir alone in lamivudine-resistant HBeAg-negative chronic hepatitis B patients
-
Rapti IN, Dimou E, Mitsoula P, Hadziyannis SJ. Combination of adefovir dipivoxil with lamivudine vs. adefovir alone in lamivudine-resistant HBeAg-negative chronic hepatitis B patients. Hepatology 2006; 44 Suppl 1:558A.
-
(2006)
Hepatology
, vol.44
, Issue.SUPPL. 1
-
-
Rapti, I.N.1
Dimou, E.2
Mitsoula, P.3
Hadziyannis, S.J.4
|